Medgyn Bierer and Sopher Forceps and Laminaria pictured in article.
MedGyn Endosampler was used to determine the expression patterns of prokineticin 1 (PROK1) and leukemia inhibitory factor (LIF) in normal fertile women with idiopathic recurrent pregnancy loss (RPL).
With the increase use of Endometrial biopsy devices like Medgyn’s Endosampler, this study was performed on random trail in a outpatient clinic. The study found Medgyn’s Endosampler to obtain substantially lower insertion rates compared to other sampling devices, which positively reflects the efficiency of Medgyn’s Endosampler.
A study estimated the cut-off of microvascular density determinative of good endometrial receptivity that can predict the fertility of the patient and be used as a prognostic marker in infertile patients, particularly in developing countries.
A study in the Journal of Reproductive Medicine reviewed current literature addressing the technique, efficacy, safety and acceptability of cryotherapy. The review found cryotherapy to be very affordable and feasible to integrate into cervical cancer screening and treatment programs.
A study published in the Egyptian Journal of Pathology investigated the role of uterine natural killer cells and E-cadherin in human endometrium of nonpregnant women and of those with recurrent abortion to find out their role in implantation or recurrent abortion.
A study comparing the adequacy of endometrial sampling by the Endosampler® and the Pipelle® showed that the Endosampler® collected more endometrium than the Pipelle®. This may well translate into a higher adequacy of specimen obtained by the Endosampler®.
We offer a full range of high-quality obstetric and gynecology products including equipment, disposables and instruments to meet the needs of healthcare professionals worldwide
Subscribe to receive news by email